Bacterial infections of the lung in normal and immunodeficient patients

Novartis Foundation Symposium

Volumn 279, Issue , 2006, Pages 42-51

  Speert, David P ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL INFECTION; COMPARATIVE STUDY; HUMAN; IMMUNE DEFICIENCY; IMMUNOCOMPETENCE; IMMUNOLOGY; LUNG; MICROBIOLOGY; PATHOLOGY; PNEUMONIA; REVIEW;

BACTERIAL INFECTIONS; HUMANS; IMMUNOCOMPETENCE; IMMUNOCOMPROMISED HOST; IMMUNOLOGIC DEFICIENCY SYNDROMES; LUNG; PNEUMONIA;

EID: 33847763664     PISSN: 15282511     EISSN: None     Source Type: Book Series    
DOI: None     Document Type: Conference Paper

References (34)

1. Ballow M 2002 Primary immunodeficiency disorders: antibody deficiency. J Allergy Clin Immunol 109:581-591
2. Boucher RC 2004 Relationship of airway epithelial ion transport to chronic bronchitis. Proc Am Thorac Soc 1:66-70
3. Bowdish DM, Davidson DJ, Scott MG, Hancock RE 2005 Immunomodulatory activities of small host defense peptides. Antimicrob Agents Chemother 49:1727-1732
4. Boyton RJ 2005 Infectious lung complications in patients with HIV/AIDS. Curr Opin Pulm Med 11:203-207
5. Cook DN, Pisetsky DS 2004 Toll-like receptors in the pathogenesis of human disease. Nat Immunol 5:975-979
6. Cowan MJ, Gladwin MT, Shelhamer JH 2001 Disorders of ciliary motility. Am J Med Sci 321:3-10
7. Currie AJ, Speert DP, Davidson DJ 2003 Pseudomonas aeruginosa: role in the pathogenesis of the CF lung lesion. Semin Respir Crit Care Med 24:671-680
8. Dear K, Holden J, Andrews R, Tatham D 2003 Vaccines for preventing pneumococcal infection in adults. Cochrane Database Syst Rev CD000422
9. Dinarello CA 2003 Anti-cytokine therapeutics and infections. Vaccine 21 Suppl 2:S24-34
10. Ekdahl K, Truedsson L, Sjoholm AG et al 1995 Complement analysis in adult patients with a history of bacteremic pneumococcal infections or recurrent pneumonia. Scand J Infect Dis 27:111-117
11. Gallin JI 1991 Interferon-gamma in the treatment of the chronic granulomatous diseases of childhood. Clin Immunol Immunopathol 61(2 Pt 2):S100-105
12. Grimbacher B, Holland SM, Gallin JI et al 1999 Hyper-IgE syndrome with recurrent infections - an autosomal dominant multisystem disorder. N Engl J Med 340:692-702
13. Happel KI, Bagby GJ, Nelson S 2004 Host defense and bacterial pneumonia. Semin Respir Crit Care Med 25:43-52
14. Hawn TR, Verbon A, Lettinga KD 2003 et al A common dominant TLR5 stop codon polymorphism abolishes flagellin signaling and is associated with susceptibility to legionnaires' disease. J Exp Med 198:1563-1572
15. Hawn TR, Verbon A, Janer M 2005 Toll-like receptor 4 polymorphisms are associated with resistance to Legionnaires' disease. Proc Natl Acad Sci USA 102:2487-2489
16. Kobayashi SD, Voyich JM, Braughton KR et al 2004 Gene expression profiling provides insight into the pathophysiology of chronic granulomatous disease. J Immunol 172:636-643
17. Leijh PC, van Zwet TL, van Furth R 1984 Extracellular stimulation by serum proteins required for maximal intracellular killing of microorganisms by mouse peritoneal macrophages. Infect Immun 46:754-758
18. Lucero MG, Dulalia VE, Parreno RN et al 2004 Pneumococcal conjugate vaccines for preventing vaccine-type invasive pneumococcal disease and pneumonia with consolidation on x-ray in children under two years of age. Cochrane Database Syst Rev CD004977
19. Lynch JP 3rd 2001 Hospital-acquired pneumonia: risk factors, microbiology and treatment. Chest 119(2 Suppl):373S-384
20. Mason CM, Ali J 2004 Immunity against mycobacteria. Semin Respir Crit Care Med 25:53-61
21. Masten BJ 2004 Initiation of lung immunity: the afferent limb and the role of dendritic cells. Semin Respir Crit Care Med 25:11-20
22. McWilliam AS, Nelson D, Thomas JA, Holt PG 1994 Rapid dendritic cell recruitment is a hallmark of the acute inflammatory response at mucosal surfaces. J Exp Med 179:1331-1336
23. Nuorti JP, Butler JC, Gelling L, Kool JL, Reingold AL, Vugia DJ 2000 Epidemiologic relation between HIV and invasive pneumococcal disease in San Francisco County, California. Ann Intern Med 132:182-190
24. Reeves EP, Lu H, Jacobs HL et al 2002 Killing activity of neutrophils is mediated through activation of proteases by K+ flux. Nature 416:291-297
25. Schappi MG, Klein NJ, Lindley KJ et al 2003 The nature of colitis in chronic granulomatous disease. J Pediatr Gastroenterol Nutr 36:623-631
26. Segreti J, House HR, Siegel RE 2005 Principles of antibiotic treatment of community-acquired pneumonia in the outpatient setting. Am J Med 118(Suppl 7A):21S-28
27. Shaw MJ 2005 Ventilator-associated pneumonia. Curr Opin Pulm Med 11:236-241
28. Speert DP 2002 Advances in burkholderia cepacia complex. Paediatr Respir Rev 3:230-235
29. Speert DP, Bond M, Woodman RC, Curnutte JT 1994 Infection with Pseudomonas cepacia in chronic granulomatous disease: role of nonoxidative killing by neutrophils in host defense. J Infect Dis 170:1524-1531
30. Standiford TJ, Deng JC 2004 Immunomodulation for the prevention and treatment of lung infections. Semin Respir Crit Care Med 25:95-108
31. Twigg HL 3rd 2004 Macrophages in innate and acquired immunity. Semin Respir Crit Care Med 25:21-31
32. Wang Q, Doerschuk CM, Mizgerd JP 2004 Neutrophils in innate immunity. Semin Respir Crit Care Med 25:33-41
33. Watt JP, Levine OS, Santosham M et al 2003 Global reduction of Hib disease: what are the next steps? Proceedings of the meeting Scottsdale, Arizona, September 22-25, 2002. J Pediatr 143(6 Suppl): S163-187
34. Winkelstein JA, Marino MC, Johnston RB Jr et al 2000 Chronic granulomatous disease. Report on a national registry of 368 patients. Medicine (Baltimore) 79:155-169